An international study to test drugs that may prevent or delay Alzheimer’s disease is adding a third drug arm. Participants...Washington University School of Medicine
Ongoing international research led by Washington University investigators is changing the Alzheimer’s disease landscape from hopeless to hopeful.Innovate magazine
An experimental Alzheimer’s drug that had previously appeared to show promise in slowing the deterioration of thinking and memory has...The New York Times - November 2016
Dominantly Inherited Alzheimer Network Trial (DIAN-TU-001) continues despite results from Eli Lilly and Company’s EXPEDITION3 trialDIAN-TU - November 2016
Nobody knew each other’s name. Even so, 60 people who either were at risk of having an autosomal-dominant Alzheimer’s mutation,...Alzforum - July 2016
Washington University School of Medicine in St. Louis has received a $4.3 million award from the Alzheimer’s Association to expand...